Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sol Efroni

Showing results (71-80 of 72) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 72 results.
Hepatology (Baltimore, Md.)|November 25, 2010
Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinomaRobert J Clifford, Jinghui Zhang, Daoud M Meerzaman, et al.
Science Signaling|January 22, 2015
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancerNir Ben-Chetrit, David Chetrit, Roslin Russell, et al.
Pageof 8

Showing results (71-80 of 72) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 72 results.
Hepatology (Baltimore, Md.)|November 25, 2010
Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinomaRobert J Clifford, Jinghui Zhang, Daoud M Meerzaman, et al.
Science Signaling|January 22, 2015
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancerNir Ben-Chetrit, David Chetrit, Roslin Russell, et al.
Pageof 8